Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital

ABSTRACT: Objectives: To describe the incidence of thromboembolic events in adult patients with severe COVID-19 and identify clinical and laboratory factors associated with these events. Design: Observational retrospective cohort study of 243 adult patients with severe COVID-19 admitted to an inten...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Antonio Adolfo Guerra Soares Brandão, Cleyton Zanardo de Oliveira, Salomon Ordinola Rojas, Amanda Ayako Minemura Ordinola, Victoria Masi Queiroz, Danielle Leão Cordeiro de Farias, Phillip Scheinberg, Viviane Cordeiro Veiga
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/dd48be2d2a904564a51518f19135dfe1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dd48be2d2a904564a51518f19135dfe1
record_format dspace
spelling oai:doaj.org-article:dd48be2d2a904564a51518f19135dfe12021-11-12T04:27:24ZThromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital1201-971210.1016/j.ijid.2021.10.020https://doaj.org/article/dd48be2d2a904564a51518f19135dfe12021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1201971221008122https://doaj.org/toc/1201-9712ABSTRACT: Objectives: To describe the incidence of thromboembolic events in adult patients with severe COVID-19 and identify clinical and laboratory factors associated with these events. Design: Observational retrospective cohort study of 243 adult patients with severe COVID-19 admitted to an intensive care unit (ICU) at a Brazilian tertiary hospital. Results: The incidence of all thromboembolic events was 14.8%, in which 3.8% developed deep vein thrombosis, 7.8% pulmonary embolism, 2.5% acute myocardial infarction, 1.2% stroke, and 1.2% peripheral artery occlusion. Risk factors identified were D-dimer at admission >3000 ng/mL (P=<0.0013) and major bleeding (P=0.001). The cumulative risk of developing thromboembolic events at day 28 after ICU admission was 16.0%. The rate of major bleeding was 4.1%. After receiver operating characteristic curve analysis, the D-dimer cut-off at admission correlating with thromboembolic events was 1140.5 ng/mL. Conclusions: The rate of thromboembolic events in our study was lower than previously described. High D-dimer level at admission was the leading risk factor; the optimal cut-off was 1140.5 ng/mL. The occurrence of thromboembolic events did not have an impact on the median overall survival rate. The optimal anticoagulant strategy in this context still needs to be established.Antonio Adolfo Guerra Soares BrandãoCleyton Zanardo de OliveiraSalomon Ordinola RojasAmanda Ayako Minemura OrdinolaVictoria Masi QueirozDanielle Leão Cordeiro de FariasPhillip ScheinbergViviane Cordeiro VeigaElsevierarticleCOVID-19intensive care unitthrombosisD-dimersurvivalInfectious and parasitic diseasesRC109-216ENInternational Journal of Infectious Diseases, Vol 113, Iss , Pp 236-242 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
intensive care unit
thrombosis
D-dimer
survival
Infectious and parasitic diseases
RC109-216
spellingShingle COVID-19
intensive care unit
thrombosis
D-dimer
survival
Infectious and parasitic diseases
RC109-216
Antonio Adolfo Guerra Soares Brandão
Cleyton Zanardo de Oliveira
Salomon Ordinola Rojas
Amanda Ayako Minemura Ordinola
Victoria Masi Queiroz
Danielle Leão Cordeiro de Farias
Phillip Scheinberg
Viviane Cordeiro Veiga
Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital
description ABSTRACT: Objectives: To describe the incidence of thromboembolic events in adult patients with severe COVID-19 and identify clinical and laboratory factors associated with these events. Design: Observational retrospective cohort study of 243 adult patients with severe COVID-19 admitted to an intensive care unit (ICU) at a Brazilian tertiary hospital. Results: The incidence of all thromboembolic events was 14.8%, in which 3.8% developed deep vein thrombosis, 7.8% pulmonary embolism, 2.5% acute myocardial infarction, 1.2% stroke, and 1.2% peripheral artery occlusion. Risk factors identified were D-dimer at admission >3000 ng/mL (P=<0.0013) and major bleeding (P=0.001). The cumulative risk of developing thromboembolic events at day 28 after ICU admission was 16.0%. The rate of major bleeding was 4.1%. After receiver operating characteristic curve analysis, the D-dimer cut-off at admission correlating with thromboembolic events was 1140.5 ng/mL. Conclusions: The rate of thromboembolic events in our study was lower than previously described. High D-dimer level at admission was the leading risk factor; the optimal cut-off was 1140.5 ng/mL. The occurrence of thromboembolic events did not have an impact on the median overall survival rate. The optimal anticoagulant strategy in this context still needs to be established.
format article
author Antonio Adolfo Guerra Soares Brandão
Cleyton Zanardo de Oliveira
Salomon Ordinola Rojas
Amanda Ayako Minemura Ordinola
Victoria Masi Queiroz
Danielle Leão Cordeiro de Farias
Phillip Scheinberg
Viviane Cordeiro Veiga
author_facet Antonio Adolfo Guerra Soares Brandão
Cleyton Zanardo de Oliveira
Salomon Ordinola Rojas
Amanda Ayako Minemura Ordinola
Victoria Masi Queiroz
Danielle Leão Cordeiro de Farias
Phillip Scheinberg
Viviane Cordeiro Veiga
author_sort Antonio Adolfo Guerra Soares Brandão
title Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital
title_short Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital
title_full Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital
title_fullStr Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital
title_full_unstemmed Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital
title_sort thromboembolic and bleeding events in intensive care unit patients with covid-19: results from a brazilian tertiary hospital
publisher Elsevier
publishDate 2021
url https://doaj.org/article/dd48be2d2a904564a51518f19135dfe1
work_keys_str_mv AT antonioadolfoguerrasoaresbrandao thromboembolicandbleedingeventsinintensivecareunitpatientswithcovid19resultsfromabraziliantertiaryhospital
AT cleytonzanardodeoliveira thromboembolicandbleedingeventsinintensivecareunitpatientswithcovid19resultsfromabraziliantertiaryhospital
AT salomonordinolarojas thromboembolicandbleedingeventsinintensivecareunitpatientswithcovid19resultsfromabraziliantertiaryhospital
AT amandaayakominemuraordinola thromboembolicandbleedingeventsinintensivecareunitpatientswithcovid19resultsfromabraziliantertiaryhospital
AT victoriamasiqueiroz thromboembolicandbleedingeventsinintensivecareunitpatientswithcovid19resultsfromabraziliantertiaryhospital
AT danielleleaocordeirodefarias thromboembolicandbleedingeventsinintensivecareunitpatientswithcovid19resultsfromabraziliantertiaryhospital
AT phillipscheinberg thromboembolicandbleedingeventsinintensivecareunitpatientswithcovid19resultsfromabraziliantertiaryhospital
AT vivianecordeiroveiga thromboembolicandbleedingeventsinintensivecareunitpatientswithcovid19resultsfromabraziliantertiaryhospital
_version_ 1718431320795774976